Ladenburg Thalmann Financial Services’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $90K | Sell |
10,557
-1,832
| -15% | -$15.6K | ﹤0.01% | 3106 |
|
|
2019
Q3 | $113K | Sell |
12,389
-1,800
| -13% | -$16.4K | ﹤0.01% | 2850 |
|
|
2019
Q2 | $151K | Buy |
14,189
+727
| +5% | +$7.74K | ﹤0.01% | 2672 |
|
|
2019
Q1 | $129K | Sell |
13,462
-1,467
| -10% | -$14.1K | ﹤0.01% | 2725 |
|
|
2018
Q4 | $172K | Sell |
14,929
-5,833
| -28% | -$67.2K | ﹤0.01% | 2341 |
|
|
2018
Q3 | $352K | Buy |
20,762
+3,650
| +21% | +$61.9K | ﹤0.01% | 1875 |
|
|
2018
Q2 | $325K | Hold |
17,112
| – | – | ﹤0.01% | 1876 |
|
|
2018
Q1 | $325K | Sell |
17,112
-2,077
| -11% | -$39.4K | ﹤0.01% | 1876 |
|
|
2017
Q4 | $314K | Buy |
19,189
+7,900
| +70% | +$129K | ﹤0.01% | 1874 |
|
|
2017
Q3 | $169K | Buy |
11,289
+549
| +5% | +$8.22K | ﹤0.01% | 2230 |
|
|
2017
Q2 | $94K | Buy |
10,740
+3,000
| +39% | +$26.3K | ﹤0.01% | 2553 |
|
|
2017
Q1 | $41K | Buy |
7,740
+940
| +14% | +$4.98K | ﹤0.01% | 3062 |
|
|
2016
Q4 | $21K | Buy |
6,800
+2,300
| +51% | +$7.1K | ﹤0.01% | 3453 |
|
|
2016
Q3 | $21K | Hold |
4,500
| – | – | ﹤0.01% | 3380 |
|
|
2016
Q2 | $26K | Sell |
4,500
-119
| -3% | -$688 | ﹤0.01% | 3162 |
|
|
2016
Q1 | $28K | Hold |
4,619
| – | – | ﹤0.01% | 3023 |
|
|
2015
Q4 | $42K | Buy |
4,619
+1,000
| +28% | +$9.09K | ﹤0.01% | 2688 |
|
|
2015
Q3 | $20K | Hold |
3,619
| – | – | ﹤0.01% | 3109 |
|
|
2015
Q2 | $40K | Hold |
3,619
| – | – | ﹤0.01% | 2747 |
|
|
2015
Q1 | $57K | Hold |
3,619
| – | – | ﹤0.01% | 2457 |
|
|
2014
Q4 | $55K | Hold |
3,619
| – | – | ﹤0.01% | 2300 |
|
|
2014
Q3 | $39K | Hold |
3,619
| – | – | ﹤0.01% | 2197 |
|
|
2014
Q2 | $55K | Sell |
3,619
-81
| -2% | -$1.23K | ﹤0.01% | 1985 |
|
|
2014
Q1 | $67K | Hold |
3,700
| – | – | ﹤0.01% | 1754 |
|
|
2013
Q4 | $51K | Buy |
3,700
+3,500
| +1,750% | +$48.2K | ﹤0.01% | 1903 |
|
|
2013
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 3469 |
|
|
2013
Q2 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 3338 |
|